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ABSTRACT 
Objective: To investigate kinetic changes in the spectral characteristics by Fourier Transform Infrared spectroscopy (FTIR) of water-lactose 
complexes (SMC), derived during the manufacturing process of the drug, containing release-active forms of antibodies. 
Methods: lactose monohydrate substance, saturated with release-active forms of affinity-purified polyclonal rabbit antibodies to recombinant human 
interferon-gamma (RA forms of Abs); tablets produced from this substance by direct compression after the addition of excipients (microcrystalline cellulose, 
magnesium stearate). Powdered and tableted placebo samples saturated with technologically processed water or phosphate-buffered saline, as well as with 
intact ethanol were used as control. Kinetic changes in SMC were studied using an Agilent Cary 630 FTIR spectrophotometer with a diamond ATR accessory 
(Agilent Technologies, USA). We used the method of X-ray fluorescence spectroscopy (EDX-7000 Shimadzu energy dispersive X-ray fluorescence 
spectrometer) to track changes in the fluorescence signal at certain wavelengths. The range of measured elements–11Na-92U. 
Results: Control of some technological characteristics of the obtained active substance (moisture, flowability) and dosage form (mean mass, 
disintegration rate) was used as indirect indicators of quality, but they did not allow reliably distinguishing intact lactose from the saturated one. 
Long-period oscillations on FTIR spectra were characteristic for all types of samples; oscillations occur at approximately two-week intervals; S/N 
indices were more stable for samples of RA forms of Abs than for placebo samples. On some days, the substance saturated with RA forms of Abs 
significantly differed from the intact lactose powder. The kinetics of the X-ray fluorescence intensity at certain wavelengths indicates the possibility 
of a periodic cooperative trigger transition of the system. Reversible conformational transitions are observed for powders on the 30th and 130th days (Kα 3.313 keV). For tablets at Kα 3.313 keV and Kα 1.740 keV small changes were visualized on those days (100–110th day) when hysteresis 
phenomena were recorded in the IR spectra of these samples. 
Conclusion: As a result, the evidence for a long-period dramatic conformational mobility of the water-lactose complex was obtained. Based on the 
data on the semiannual kinetics of IR spectra, a universal criterion for the identity of lactose powder saturated with RA forms of Abs was obtained. 
Also, it was confirmed that the lactose conformation state was changed by saturation with RA forms of Abs. 
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INTRODUCTION 
For more than ten years among the antiviral drugs duly registered in 
the State Register of the Russian Federation, there have been several 
drugs of the so-called release-active forms of antibodies. Anaferon 
for Children (reg. number LP-N (000035)-(RG-RU)) is widely used in 
pediatric practice for the successful treatment of various infectious 
diseases not only in Russia but also in many countries. The 
effectiveness has been proven in preclinical and clinical studies and 
noted in many publications [1-3].  
Our previous works were devoted to the study of the influence of 
sample preparation conditions (grinding, saturation with a solvent, 
etc.) on the physicochemical characteristics of lactose monohydrate 
powder, which is used as a carrier of the active substance in these 
drugs [4]. The presence of critical differences in the differential IR 
spectra, in the spectra within the terahertz region between the 
sample of intact lactose substance and the powder, which 
underwent the fluidization procedure with the introduction of the 
active substance in an aerosol chamber, was shown [5]. We 
substantiated the results obtained by the possibility of the formation 
of supramolecular structures of water-lactose complexes in the 
amorphous and quasicrystalline state (fig. 1). 
In addition to the special spectral characteristics that present the specific 
organization, the supramolecular water-lactose complex (SMC) also 
demonstrates the biological activity relative to the unicellular model of S. 
ambigua [6]. It is noteworthy that all of the above properties disappear 
upon drying of powdered preparations, which directly indicates the role 
of water in the formation of release-active SMCs. 
 
 
Fig. 1: The formation of a water-lactose complex (SMC) and reversible transitions between the conformational states of the amorphous 
RA forms of Abs system (L–lactose, W–H2O, LmWn*–RA forms of Abs) 
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The clinical efficacy of drugs based on RA forms of Abs can be 
interpreted as a test of their biological activity at the population 
level [3]. Since the concentration of Abs proper after potentiation is 
zero, therefore, it is necessary to detect the formation of a specific 
supramolecular water-lactose complex during physicochemical 
standardization and quality control. 
In preliminary experiments, we showed that SMCs undergo slow 
conformational transformations with monthly kinetics. The observed 
kinetic transitions suggest the existence of a free energy barrier between 
the states of the supramolecular structure. The process can be compared 
with the kinetic trapping phenomenon, well studied, and described for 
protein molecules, associated with conformational differences between 
the long-lived transitional and stable final states [7, 8]. 
This paper presents the results of a study of the multi-month 
kinetics of RA forms of Abs: considering the possible oscillations of 
the supramolecular structure, we have registered characteristic 
changes in the FTIR spectra. Bearing in mind that the energy-
saturated supramolecular complexes must undergo hysteresis and 
trigger conformational transitions (fig. 1), we also used trace 
elements as a kind of sensors for changes in the dielectric constant 
inside the SMCs. By analogy with the use of RCS-tags in the study of 
conformational transitions of high molecular systems [9], we used 
the method of X-ray fluorescence spectroscopy [10] to track changes 
in the fluorescence signal at certain wavelengths. 
MATERIALS AND METHODS 
Samples under investigation 
All samples for the research were obtained directly from the 
manufacturer (Matera Medica Holding, Russia)–a lactose powder, as 
well as the experimental tablets. 
The lactose powder we used presented the powder of lactose 
monohydrate C12H22O11·H2O (Super Tab 30GR, DFE Pharma, 
Germany), which was saturated with release-active forms of affinity-
purified polyclonal rabbit antibodies to recombinant human 
interferon-gamma using the technology of applying substances in a 
fluidized bed [4]. Flat-cylindrical tablets were produced from this 
substance by direct compression after the addition of excipients 
(microcrystalline cellulose, magnesium stearate) and were not 
commercially available drugs. RA forms of Abs was produced by the 
technology of ultra-high dilutions as described in [4] and in the 
US patent 8 535 664 with the initial substance dilution factor (1024). 
As a control, we used powdered and tableted placebo samples 
obtained by the same method, from the same series of lactose and 
excipients, but only saturated during fluidization with 
technologically processed (i.e. underwent the same technological 
dilution process as the antibodies) water (saturation control), 
technologically processed phosphate-buffered saline (control of 
antibody solvent) and intact ethanol (process control). Thus, a total 
of 5 types of powdered and tableted samples was used in the work–
intact substance of lactose monohydrate, lactose monohydrate 
saturated with RA forms of Abs, and 3 types of control.  
The samples received from the manufacturer were stored for the 
entire observation period at a temperature not exceeding 25 °C, 
away from the source of natural and artificial lighting and heating 
devices, in undisturbed packaging. The powders for the study were 
packaged in 0.5 ml eppendorfs; each eppendorf was sealed in 
paraffin film. After opening the package and carrying out 
measurements, the powder was disposed of; for re-analysis, each 
time a new packed eppendorf with the substance was taken. The 
tablets were packaged in polymer jars of 20 ml (with tamper-evident 
caps), each tablet was measured once, after that the sample was 
disposed of and the jar was tightly sealed with paraffin film. 
Determination of technological characteristics of samples 
The flowability measurements were carried out under the requirements 
of the European Pharmacopoeia [11]: test powder mass was 100 g; the 
flowability was measured in five repetitions using PTG S4 powder and 
granule flow tester (Pharma Test Apparatebau AG (Germany)). 
The residual moisture content was determined in lactose 
monohydrate powders using an Ohaus MB45 moisture content 
analyzer (OHAUS Corporation, Switzerland): analyzing mass–5 g, 
heating–80 °C, heating duration-15 min. 
The mean mass was calculated as a result of the weighting of 10 
tablets using Ohaus Scout Pro SPU123 laboratory balance (Ohaus 
Instruments (Shanghai) Co; Ltd., China). 
Determination of tablets disintegration time was carried out on a 
disintegration tester PTZ AUTO 2 (Pharma Test Apparatebau AG, 
Germany). The test was carried out following with the requirements of 
the European pharmacopoeia-"Disintegration of tablets and capsules" 
[11]. The device for determining disintegration consists of two collecting 
baskets, two glass vessels for liquid with a capacity of 1 l, a thermostatic 
device that maintains the temperature of the liquid within (37±2) °С, and 
two electromechanical devices that impart reciprocating movement to 
the baskets at a distance of at least less than 50 and not more than 60 
mm in the vertical plane at a frequency of 28-32 cycles per minute. 
Disintegration time measurement was performed in six replicates. 
Fourier-transform IR spectroscopy 
Kinetic changes in SMC of release-active drugs were studied using an 
Agilent Cary 630 FTIR spectrophotometer with a 
diamond ATR accessory (Agilent Technologies, USA). The spectral 
range is 4000–750 cm-1. The resolution is less than 2 cm-1, the 
correctness of the wavenumber is 0.05 cm-1, the reproducibility of 
the wavenumber is 0.005 cm-1. The thickness of the absorbing layer 
is 1.5 nm (the clamping device guarantees the setting of optimal and 
reproducible pressure). Before placing the attachment on the 
crystal, all powdered samples were controlled by weight (average 
weight 5.5 mg). The tablets were also fixed with the clamping device, 
ensuring their position with the smooth side to the crystal. The 
spectra of the samples were recorded weekly for 6 mo. 
The standard Agilent MicroLab Expert software was used to control 
the device, measure the data, and evaluate the quality of the 
obtained spectra; in this case, the FTIR spectra visualized in the 
wave number in the coordinates, cm-1–reflection, %. All subsequent 
mathematical transformations of the spectral data array were 
performed using the OriginPro 2015 software (OriginLab, USA).  
For samples containing only intact lactose, the average spectrum 
was calculated based on the results of measurements of 6 samples. 
The spectral data of all saturated lactose samples were further 
transformed as follows: the corresponding "background"–the 
spectrum of intact lactose averaged over the results of 6 
measurements–was subtracted from the spectrum of each sample 
(for example, the spectrum of sample 1p averaged over 6 
measurements was subtracted from the spectrum of the first 
specimen of sample 2p). The obtained results–difference spectra–for 
each sample were averaged over the number of replicates (n = 6) 
and the standard deviation was calculated. The results of data 
analysis presented the wavenumber graphically in the coordinates, 
cm-1–the ratio of the average difference spectrum to the standard 
deviation spectrum (signal to noise ratio–S/N). 
Such S/N spectra were recorded once a week during the entire study 
period for all 10 samples divided into groups–powders and tablets. 
On certain days of the study, significant (S/N>2) differences were 
visualized between the RA forms of Abs and placebo samples. To 
estimate the frequency of SMC oscillations in powders and tablets 
for the entire observation period, kinetic curves of the weekly 
change in the S/N value were plotted at points 1700 (oscillation 
frequency of the carbonyl group), 3250 and 3450 cm-1 (oscillation 
frequencies of the O-H bond). 
X-ray fluorescence spectroscopy 
An EDX-7000 Shimadzu energy dispersive X-ray fluorescence 
spectrometer was used in the study. The range of measured 
elements–11Na-92U; X-ray generator–a tube with an Rh-anode, air-
cooled; voltage 4–50 kV, current 1–1000 μ A; irradiated area–a circle 
of 10 mm in diameter; silicon drift detector (SDD), counting 
method–a digital counting filter; the content of elements according 
to the value of intensity; automatic change of filters emitting the 
wavelengths of the corresponding elements; chamber size 300 mm x 
275 mm x 100 mm. 
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The kinetics of the signal intensity obtained at certain wavelengths 
of each of the 10 samples submitted for analysis was investigated 
once a week throughout the entire study period (6 mo).  
The initial sample of tablets or powder did not require special 
sample preparation. 
The content of a microtube (eppendorf) or a tablet was placed in a 
closed-type cuvette and covered with mylar (polyethylene 
terephthalate) film. The irradiated area was controlled by a 
collimator and was 10 mm for the powder and 5 mm for the tablet. The investigated wavelengths were K Kα 3.313 keV (3.7424 Å); Si Kα 
1.740 keV (7.1255 Å). The measurement time was 50 seconds at 
each wavelength. 
The results obtained using the XRF method are presented in values 
of irradiation intensity expressed in cps/µA (cps is the line intensity 
in standard units (counting per second), µA is the current intensity). 
For each of 10 samples, 6 spectra were recorded weekly. The kinetic 
curves of changes in the signal intensity at a certain wavelength 
were plotted based on averaged values. 
RESULTS 
In the production of release-active drugs, the stage of saturation 
of the lactose monohydrate substance with RA forms of Abs is 
critical [12]. Control of some technological characteristics of the 
obtained active substance–moisture and flowability-are used by 
the manufacturer as indirect indicators of its quality, but they do 
not allow reliably distinguishing intact lactose from the 
saturated one. A similar problem concerning the finished dosage 
form–tablets–seems to be unsolvable, taking into account the 
presence of excipients. The technological characteristics of the 
samples under investigation were determined directly by the 
manufacturer and are presented for powders–in table 1, for 
tablets–in table 2. 
 
Table 1: Technological characteristics of powdered samples 
Sample Composition Loss on drying, % Flowability±SD*, s per 100 g  
1p Lactose monohydrate 0.20 17.1±0.7 
2p Lactose monohydrate saturated with RA forms of Abs 0.18 15.7±1.0 
3p Lactose monohydrate saturated with technologically processed 
phosphate-buffered saline 
0.16 17.6±4.2 
4p Lactose monohydrate saturated with technologically processed water 0.20 16.5±3.6 
5p Lactose monohydrate saturated with ethanol 0.16 12.9±0.7 
*n = 5, SD-standard deviation 
 
Table 2: Technological characteristics of tableted samples 
Sample Composition Mean mass±SD*, mg Disintegration±SD**, s 
1t Lactose monohydrate 296.3±3.1 246.7±44.7 
2t Lactose monohydrate saturated with RA forms of Abs, microcrystalline 
cellulose, magnesium stearate 
299.8±4.0 286.7±55.0 
3t Lactose monohydrate saturated with technologically processed phosphate-
buffered saline, microcrystalline cellulose, magnesium stearate 
302.9±3.2 366.2±68.5 
4t Lactose monohydrate saturated with technologically processed water, 
microcrystalline cellulose, magnesium stearate 
301.5±1.6 339.5±62.6 
5t Lactose monohydrate saturated with ethanol, microcrystalline cellulose, 
magnesium stearate 
301±2.2 270.5±60.3 
*n = 10, SD-standard deviation, **n = 6, SD-standard deviation 
 
However, we showed in previous works that differential IR 
spectroscopy could be a useful tool in assessing the degree of lactose 
fluidization [5]. Considering that chemically intact and saturated 
lactose are the same substance, their IR spectra do not differ in the 
frequency arrangement of absorption ranges, however, the 
formation of water-lactose SMCs should be presented in the values 
of their intensity. If we consider the supramolecular structure of the 
water-lactose complex as a quasicrystalline system with excess bond 
energy, then its conformational changes can be predicted, and the 
signal in the IR spectra should also change with time. 
Results of the study of long-period kinetics of water-lactose SMC 
by IR spectroscopy 
For 6 mo, once a week, we recorded and processed the FTIR 
spectra of powdered and tableted lactose samples in the infrared 
range according to the method described above. The differential 
spectra of the samples presented graphically in the "wave number-
S/N" coordinates did not coincide with each other from week to 
week (fig. 2), which confirms the assumption about the 




Fig. 2: Examples of S/N spectra on each day of measurements: A–powders on day 82 from the date of production, B–powders on day 131 
from the date of production (red–sample 2p, green–3p, dark gray–4p, gray–5p), n=6 
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According to generally adopted analytical approaches, the presence 
of an instrumental response can be said when the signal-to-noise 
ratio is from 3:1 to 2:1. Thus, we see that on some days of 
measurements (fig. 2B), the substance saturated with RA forms of 
Abs, according to the data of spectral analysis, significantly differed 
from the intact lactose powder. Similar results were obtained for 
tablets, but the number of measurements, when it was possible to 
reveal spectral differences, turned out to be significantly lower in 
comparison with powders. 
Fig. 3 shows graphs presenting changes in time of the averaged 
spectrum of intact lactose at the frequency of 3250 cm-1. It can be 
seen that the reflection value for intact lactose remains stable 
throughout the entire study period. It can be assumed that the 
variations in the signal-to-noise (S/N) spectra (fig. 2) are not caused 
by an error of the device, by the dispersity or other characteristics of 
the intact lactose powder, but by the long-period conformational 





Fig. 3: Signal stability control for intact lactose–kinetics of reflection signal values at 3250 cm-1; (A–powders, B–tablets), n=6 
 
Below are some of the obtained kinetic curves of changes in the S/N 
value for the samples under investigation at points 1700, 3250, and 
3450 cm-1– the results of the kinetic study of powders in fig. 4, 






Fig. 4: Kinetics of S/N values for powders at 1700 cm-1 (A) and 3450 cm-1 (B), red–sample 2p, green–3p, dark gray–4p, gray–5p, n=6. The 






Fig. 5: Kinetics of S/N values for tablets at 1700 cm-1(A) and 3250 cm-1 (B), red–sample 2t, green–3t, dark gray–4t, gray–5t, n=6. The 
arrows indicate the time moments when the SMCs of RA forms of Abs exhibit oscillations in the antiphase relative to the controls 
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A detailed examination of the dependences obtained (fig. 4, fig. 5) 
allows drawing some general conclusions: for example, long-
period oscillations are characteristic for all types of samples–
powders of the substance and the finished dosage form, regardless 
of the type of saturating solution; oscillations occur at 
approximately two-week intervals; S/N indices are more stable 
(have a lower average amplitude) for samples of RA forms of Abs 
than for placebo samples. For powders, the 30th and 130th days 
are critical–oscillations in the SMCs of RA forms of Abs are in 
antiphase relative to other controls, which allows registering the 
fact of saturation of the lactose powder (fig. 4). According to the 
results of kinetic studies (fig. 5), on the 110th d, there are observed 
differences between the tableted RA forms of Abs and placebo 
samples, which correlates with the results obtained by the XRF 
method. 
Having paid attention to the difference in the oscillation amplitudes of 
the samples saturated with the active substance and control solutions, 
we calculated the median values of S/N magnitudes (at 1700, 3250, 
and 3450 cm-1) based on the data of the spectra recorded weekly for 
each of the samples throughout the entire study period. In the group of 
powders, this value has the smallest meaning for sample 2p (API 
substance). In the group of tableted samples at the specified 
frequencies, it always takes the highest value for sample 2t (RA forms 
of Abs tablets). An example of fulfilling this identity criterion based on 
measurements for 23 w is shown in table 3. 
 
Table 3: Median S/N values over a long period of observation (>10 w) 
Powder 
samples 
Oscillation recording frequency Tablet 
samples 
Oscillation recording frequency 
1700 cm-1 3250 cm-1 3450 cm-1 1700 cm-1 3250 cm-1 3450 cm-1 
2p 0.65 0.47 0.73 2t 0.1 0.15 0.004 
3p 0.92 0.61 1.01 3t -0.19 -0.18 -0.45 
4p 0.99 1.37 1.74 4t -0.21 -0.15 -0.23 
5p 1.25 1.01 1.09 5t -0.40 -0.46 -0.74 
 
Results of the water-lactose SMC study by X-ray fluorescence 
spectroscopy 
The XRF method in the framework of this study was used as a 
marker of the transition of conformational states of the 
supramolecular complex of the water-lactose conglomerate. The 
elemental composition of the samples could not change qualitatively 
and quantitatively during the experiment. However, the kinetics of 
the fluorescence intensity at certain wavelengths indicates the 
possibility of a periodic cooperative trigger transition of the system, 
which was recorded during the study. Experimentally, the 
wavelengths that are sensitive to conformational transitions 
between the energy states of the amorphous system and, 
accordingly, reflecting the kinetic changes of the samples in terms of 
the intensity of fluorescence signals were established–K Kα 3.313 
keV (3.7424 Å) and Si Kα 1.740 keV (7.1255 Å). 
Thus, according to the data presented in fig. 6, such reversible 
conformational transitions are observed for powders on the 30th and 130th days (Kα 3.313 keV). For tablets, no pronounced 
transitions were observed, but at Kα 3.313 keV and Kα 1.740 keV, 
small changes were visualized just on those days (100–110th day) 
when hysteresis phenomena were recorded in the IR spectra of 
these samples (fig. 5). 
 
 
Fig. 6: Kinetics of changes in the intensity of X-ray fluorescence in the studied samples of powders at the wavelength of Kα 3.313 keV 
(3.7424 Å), n=6 
 
Note once again that a change in the fluorescence signal of the same 
sample is not associated with a change in the content of an element 
(K or Si), but shows a cooperative trigger transition of the 
amorphous system, in which the trace elements included in the 
water-lactose cluster change their position relative to a surface. 
DISCUSSION 
The manufacture of high-quality drugs of release-active antibodies 
requires effective incoming control of raw materials, assurance of the 
consistency of technological parameters of production, as well as 
objective characteristic of the saturated substance of lactose, which is 
used to obtain finished dosage forms. The fold of initial antibodies 
dilution is extremely high and even taking into account the presence of 
the initial substance as nanoassociates in RA forms of Abs showed 
before [13, 14] it is necessary to detect not a change in the chemical 
composition of the substance, but the formation of a specific 
supramolecular water-lactose complex, which is characterized by 
several properties [5, 6]. The phenomenon of the formation of water-
lactose complexes has been studied by the broadband dielectric 
spectroscopy technique in the frequency range of 10−1–106 Hz and the 
temperature range of 176–230 K [15] and is beyond doubt-lactose is 
one of the main solid (after desiccation) components in milk and it 
strongly interacts with water, forming a water clustered structure with ∼123 affected water molecules per lactose molecule [16]. 
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Functions of supramolecular systems are an expression of the 
collective system, therefore, traditional characterization methods, 
such as the determination of the structure of one supermolecule at a 
time is not sufficient to characterize them. Kinetic studies are 
essential for such systems because they are dynamic [17]. Time-
resolved spectroscopic techniques, such as infra-red spectroscopy, 
can be useful for the study of supramolecular dynamics [18]. 
Moreover in [19] authors utilize Fourier transform infrared 
spectroscopy to investigate kinetics of a series of five DNA 
sequences to clarify the commonly observed physical processes. As a 
result of our study, it was shown that SMCs in the composition of 
drugs undergo hysteresis phenomena, exhibiting long-period 
conformational mobility, which probably should be taken into 
account when the drug is tested in vitro [8, 12]. Hysteresis 
phenomena in water-lactose SMCs illustrated by the results of two 
spectral methods of analysis are most likely associated with the 
influence of environmental factors such as variations in relative 
humidity, temperature, background variations in the level of natural 
radioactivity, including the flux of thermal neutrons [20, 21], which 
can be a source of energy for conformational rearrangements [22, 
23]. Based on the results of long-period observations of FTIR 
spectra, data on the transfer of energy from high-potentiated 
clusters of RA forms of Abs to "gangue material" (intact lactose 
powder) were obtained, which indicates the possibility of "dry" 
potentiation–activation of water-lactose complexes in the absence of 
water.  
CONCLUSION 
It was shown that differential IR spectra of the saturated lactose 
substance and the finished dosage form of RA forms of Abs revealed 
kinetic changes reflecting the energy transitions of the supramolecular 
system and appearing at two-week intervals. The XRF data, where the 
fluorescence signal was used as a tag of conformational mobility, 
correlates with the results obtained. At the same time, it was shown 
that in case of long-term (>10 w) observation of changes in the IR 
spectra, the median S/N values (at 1700, 3250, and 3450 cm-1) of RA 
forms of Abs are always minimal in comparison with placebo samples 
for powders and vice versa are maximal for tablets. Thus, the features 
of kinetic changes confirm that lactose state is changed by saturation 
with the RA forms of Abs and it should be considered when the 
product is tested in vitro by different analytical tools. 
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